Appendix 4D, Half-year report of 30th June, 2019, has been lodged with the Australian Securities Exchange.
View Appendix 4D Half-year report.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal